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Abstract
Background: Silver nanoparticles (AgNps) have attracted much interest in biomedical engineering, since they have
excellent antimicrobial properties. Therefore, AgNps have often been considered for incorporation into medical
products for skin pathologies to reduce the risk of contamination. This study aims at evaluating the antimicrobial
effectiveness of AgNps stabilized by pluronic™ F68 associated with other polymers such as polyvinyl alcohol (PVA)
and polyvinylpyrrolidone (PVP).
Methods: AgNps antimicrobial activity was evaluated using the minimum inhibitory concentration (MIC) method.
The action spectrum was evaluated for different polymers associated with pluronic™ F68 against the gram negative
bacteria P. aeuroginosa and E. coli and the gram positive bacteria S. Aureus.
Results: AgNps stabilized with PVP or PVA and co-stabilized with pluronic™ F68 are effective against E. coli and P.
aeruginosa microorganisms, with MIC values as low as 0.78% of the concentration of the original AgNps dispersion.
The antimicrobial action against S. aureus is poor, with MIC values not lower than 25%.
Conclusions: AgNps stabilized by different polymeric systems have shown improved antimicrobial activity against
gram-negative microorganisms in comparison to unstabilized AgNps. Co-stabilization with the bioactive copolymer
pluronic™ F68 has further enhanced the antimicrobial effectiveness against both microorganisms. A poor
effectiveness has been found against the gram-positive S. aureus microorganism. Future assays are being delineated
targeting possible therapeutic applications.
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Background
Contamination of medical products is frequently caused
by the microbial adhesion of the patient’s glycoproteins,
which deposit on the devices right after the implant-
ation. Once the microbial adherence has occurred, the
adhesion leads to the formation of a biofilm, which is re-
sistant to most available therapeutic agents [1]. Therefore,
improvement of a better strategy to prevent implant asso-
ciated infections is an urgent need [2].
Silver nanoparticles (AgNps) have received a lot of atten-
tion for their antimicrobial activity because they are more
effective in terms of minimum inhibitory concentration
(MIC) than their ionic homologues (Ag+). Due to these
antimicrobial properties, their incorporation into medical
devices, tissues and other health related products promote
higher preventive infection control [3,4].
It is believed that microorganisms are less likely to de-
velop resistance to metals in comparison to conventional
antimicrobials. This happens because metals in nano-
metric form act in several vital stages of bacteria and
viruses metabolisms, so that consecutive mutations in
the microorganism structure would be required for the
development of resistance [5].
Although many earlier studies have demonstrated the
antimicrobial activity of silver nanoparticles, the mecha-
nisms involved are still not well understood. However, it
has been hypothesized that the antibacterial activity of sil-
ver nanoparticles might be related to the crystallographic
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surface structure, the surface-to-volume ratio [6,7], the
particle size [6-9], the particle shape [5] or the ionic forms
of silver salts [10-12].
Silver nanoparticles stabilization plays an important
role in their antimicrobial activity. For example, studies
demonstrated that AgNps synthesized in the presence of
different stabilizers (PVP, BSA and others) bind them-
selves to an HIV inhibitor peptide with different effective-
ness [12]. Initially, it was believed that these polymeric
systems used in drug delivery were biologically inert and
that their functions came from the ability to (I) protect
the drug/degradation active, (II) increase the half-life of
these in vivo components, (III) facilitate their diffusion
within the cell surface until the drug/active is released on
the site of action. However, this paradigm has been modi-
fied due to recent evidences that these polymeric materials
can drastically change the cellular response of microor-
ganisms [13].
Pluronic™ copolymers are known to aid a number
of therapeutic agents in their interaction with the
human body. For example, when associated with anti-
tumor agents, their concentration in tumor cells is
increased, leading to a quick sensitization of tumors
that show resistance against conventional treatments [13].
They are also capable of increasing the pharmacological
activity of several antifungal and antibacterial agents
against a large number of microorganisms [14-16]. It is
likely that these characteristics of pluronic™ copolymers
are caused by their ability to incorporate into the cell
membrane and to translocate to the inside of the cells
[13]. Inside the cells, pluronic™ may affect several cellular
functions, such as the respiration process carried out by
the mitochondrial system.
This study aims at evaluating the antimicrobial effective-
ness of silver nanoparticles stabilized by pluronic™ F68
associated with other polymers such as polyvinyl alcohol
(PVA) and polyvinylpyrrolidone (PVP). Pluronic™F68 was
chosen in this study for its hydrophile-lipophile ba-
lance, which shows a more polar characteristic, a fact
essential for its solubilization in aqueous medium du-
ring the AgNps synthesis.
Results and discussion
A low antimicrobial activity against the S. aureus micro-
organism (MO) was found for AgNps irrespective of the
stabilizing agents used (Table 1). For the PVP stabilized
samples, either in the absence or presence of pluronic™
F68, such unfavorable inhibition of microorganism growth
corresponded to a minimum inhibitory concentration
(MIC) value of 50% of the concentration of the AgNps
dispersion obtained in the synthesis process. When PVA
was used as a stabilizer, a somewhat better MIC of 25%
was observed; however, the use of pluronic™ F68 did not
improve the antimicrobial effectiveness. An unfavorable
MIC of 50% was also obtained for the AgNps stabilized
with sodium citrate alone, while the addition of pluronic™
improved the MIC value to 25%.
A high antimicrobial effectiveness against the E.coli MO
of AgNps was found for all of the studied stabilizing poly-
mers (Table 2). When PVP was used as stabilizer a MIC of
3.13% was obtained and in the presence of the pluronic™
F68 co-stabilizer the inhibition value found was 1.56%.
When PVA was used, 3.13% was obtained and when
pluronic™ was added with PVA the value decreased even
further to 0.78%, showing an improvement in the anti-
microbial activity attributed to pluronic™ F68. In the
Table 1 Minimum Inhibitory Concentration (MIC) of polymer-stabilized silver nanoparticles against S. aureus
S. aureus 10 6 CFU/mL Minimal Inhibitory Concentration
wells % AgNps/PVP/pluronic
pH 6.27
AgNps/PVA/pluronic
pH 6.25
AgNps/citrate/pluronic
pH 6.33
AgNps/citrate
pH 6.1
AgNps/PVA pH
5.91
AgNps/PVP pH
5.97
1 100 - - - - - -
2 50 - - - - - -
3 25 + - - + - +
4 12.5 + + + + + +
5 6.25 + + + + + +
6 3.13 + + + + + +
7 1.56 + + + + + +
8 0.78 + + + + + +
9 0.39 + + + + + +
10 0.20 + + + + + +
11 0.10 - - - - - -
12 - + + + + + +
(+)Showed growth of microorganism. (-) No growth of microorganisms. 11 negative control/12 positive control.
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samples stabilized with sodium citrate either alone or in
association with pluronic™ F68, MIC values found corre-
sponded to 1.56% of the initial concentration.
The antimicrobial activity of the studied AgNps
against the P. aeruginosa MO depended on the stabili-
zing agents used, but in all cases improved when pluronic™
F68 was added as a co-stabilizer (Table 3). For PVP-
stabilized AgNps the efficacy was low, with MIC
values of 50% of the initial sample concentration.
However, the effectiveness improved to a MIC of
12.5% in the presence of the pluronic™ F68 co-
stabilizer. The use of PVA showed a MIC of 50% of
the initial sample concentration and an improvement
to 6.25% in the presence of pluronic™ F68. When
sodium citrate alone was used, a MIC of 25% was
found, whereas in the presence of pluronic™ F68 the
MIC value improved to 12.5%.
The antimicrobial activity of solutions without AgNps
were also investigated. It was found that aqueous solu-
tions containing either PVA, PVP, pluronic™ F68 or so-
dium citrate were not active against microorganisms
growth (data not shown). Therefore, the antimicrobial
effectiveness of each formulation containing AgNps is
attributable to the association of AgNps with the re-
spective stabilizer and/or the co-stabilizer.
It is noteworthy that AgNps are more effective against
gram-negative microorganisms, the E. coli and the
P. aeruginosa. It is also against these strains that the
Table 2 Minimum Inhibitory Concentration (MIC) of polymer-stabilized silver nanoparticles against E. coli
E. coli 10 6 CFU/mL Minimal Inhibitory Concentration
wells % AgNp/PVP/pluronic
pH 6.27
AgNps/PVA/pluronic
pH 6.25
AgNps/citrate/pluronic
pH 6.33
AgNps/citrate
pH 6.1
AgNps/PVA pH
5.91
AgNps/PVP pH
5.97
1 100 - - - - - -
2 50 - - - - - -
3 25 - - - - - -
4 12.5 - - - - - -
5 6.25 - - - - - -
6 3.13 - - - - - -
7 1.56 - - - - + +
8 0.78 + - + + + +
9 0.39 + + + + + +
10 0.20 + + + + + +
11 0.10 - - - - - -
12 - + + + + + +
(+)Showed growth of microorganism. (-) No growth of microorganisms. 11 negative control/12 positive control.
Table 3 Minimum Inhibitory Concentration (MIC) of polymer-stabilized silver nanoparticles against P.aeruginosa
P. aeruginosa 10 6 CFU/mL Minimal Inhibitory Concentration
wells % AgNp/PVP/pluronic
pH 6.27
AgNps/PVA/pluronic
pH 6.25
AgNps/citrate/pluronic
pH 6.33
AgNps/citrate
pH 6.1
AgNps/PVA pH
5.91
AgNps/PVP pH
5.97
1 100 - - - - - -
2 50 - - - - - -
3 25 - - - - + +
4 12.5 - - - + + +
5 6.25 + - + + + +
6 3.13 + + + + + +
7 1.56 + + + + + +
8 0.78 + + + + + +
9 0.39 + + + + + +
10 0.20 + + + + + +
11 0.10 - - - - - -
12 - + + + + + +
(+)Showed growth of microorganism. (-) No growth of microorganisms. 11 negative control/12 positive control.
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pluronic™ F68 incorporation is more effective. These
results are consistent with our previous work, in which
pluronic™ F68 improved the antimicrobial effectiveness
of the ceftazidime drug, a third generation cephalosporin
with wide action spectrum, against E. coli and P. aerugi-
nosa microorganisms [17].
The use of AgNps co-stabilized by pluronic™ F68
could aid in the decrease of the resistance phenomena
[18] where the use of AgNps for burns treatment pre-
sented the onset of resistance against Enterobacteriaceas,
P.aeruginosa, Salmonella and others.
The silver antimicrobial effectiveness is increased when
incorporated in the copolymer, in comparison to pure sil-
ver nitrate. It was suggested that such phenomenon may
be related to silver inactivation by nutrient broth or by
the microorganisms themselves [19].
The silver antimicrobial effectiveness has been
acknowledged for ages. Over the last few years, the use
of silver or silver salts as key components to control the
microbial proliferation has become increasingly popular.
They are being currently incorporated in a wide variety
of materials used in our daily lives, which range from
the textile and hospital areas to materials used in per-
sonal hygiene, such as deodorants and toothbrushes
[19-22]. A recent application is based on matrixes formed
by collagen and bayberry tannin for the immobilization of
silver nanoparticles (AgNps) [23].
In order to determine the susceptibility of microor-
ganisms against AgNps, some methods reported the
importance of standardizing MIC and other studies for
AgNps evaluation when they are incorporated to me-
dical and hospital products. Another important fact is
that the presence of silver ions, resulting from the
AgNps synthesis process, also has bactericidal potential
[4,18]. For such reasons, these studies defined that the
MIC should be determined by the percentage concen-
tration (%) of the solutions obtained in each process.
these recommendations make it possible to demon-
strate the importance of stabilizing and co-stabilizing
polymers to obtain more effective particles against dif-
ferent microorganisms, as well as the evaluation of the
susceptibility of an unpurified solution composed by
AgNps and Ag ions mixture.
AgNps and Ag ions accumulate in E. coli cells protein
envelope and both AgNps and Ag ions seem to act simi-
larly inside the cell, though their effectiveness is of nano-
molar and micromolar order of magnitude for AgNps
and Ag ions, respectively [4].
Amphiphilic polymers such as the ones from the
pluronic™ class are highly relevant materials for the de-
velopment of nanoparticles for medical use. Nanoparticles
co-stabilization with pluronic™ did not show considerable
modifications in particle size. The pluronic™ addition
showed improvement also on colloidal stability and on the
nanoparticles analytic characteristic of metals demon-
strated through Raman [24].
Conclusion
AgNps stabilized by different polymeric systems have
shown improved antimicrobial activity against the gram-
negative microorganisms E. coli and P. aeruginosa in com-
parison to unstabilized AgNps. Co-stabilization with the
bioactive copolymer pluronic™ F68 has further enhanced
the antimicrobial effectiveness against both microorga-
nisms. A poor effectiveness has been found against the
gram-positive S. aureus microorganism.
Materials and methods
Silver nanoparticles synthesis
The Turkevich method for metals nanoparticle synthe-
sis has been adapted by the authors to deliver AgNps
with good antimicrobial properties [25]. The method
only involves benign substances, so it is suitable for
applications in the human body. This method was ap-
plied here with further modifications to allow incor-
poration of the polymeric stabilizers and the pluronic™
co-stabilizer. A 500 mL jacketed reactor was completely
filled with deionized water and heated to 89°C. Subse-
quently 90 mg of silver nitrate (AgNO3) and 135 mg of ei-
ther PVA or PVP polymer were added (method proposed
by Wang et al., 2004). Then 10 mL of a 1 wt% aqueous so-
lution of sodium citrate was added to the reactor using a
peristaltic pump, so that a molar ratio of silver nitrate to
sodium citrate of 1:0.68 resulted. The chemical reduction
of silver ions by citrate was allowed to proceed under con-
trolled temperature and stirring. After 20 min of reaction,
the reaction was stopped by cooling to ambient
temperature. In some experiments, after 20 min of reac-
tion 6 g of the pluronic™ F68 copolymer (molecular
weight 8,400) was added, after which the reactor was
Figure 1 Minimum Inhibitory Concentration Methodology (MIC).
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cooled to 52°C and kept at this temperature under stirring
for additional 20 min.
The amount of pluronic™ F68 added to the reaction
was determined according to the critical micelle concen-
tration/temperature. The pluronic™ mass added considers
the formation of micelles of sizes of up to 100nm. If
micelles are not formed, free monomers in the reaction
medium promote the formation of particles over 300nm,
i.e. outside the proper size range in this study.
The pH values of the AgNps dispersions were deter-
mined by a pHmeter (Accumet AR 20, Fisher Scientific,
USA) at room temperature (25°C). The pH values in all
preparations in this work were within the narrow range
of 5.9 to 6.3.
Bacterial strains
The microorganisms used were Escherichia coli ATCC
25922, Pseudomonas aeruginosa ATCC 9721 and
Staphylococcus aureus ATCC 10390. These microorga-
nisms were chosen following the recommendations of a
Committee of the Biological Section of the Pharmaceu-
tical Manufacturer’s Association and also because they
are very common in hospitals. The microorganisms
growth was carried out in 250 mL Erlenmeyer flasks,
incubated in a rotational shaker at 100 rpm and 37°C for
24 h, using 50 mL of Tryptic Soy Broth (TSB). All culti-
vation media were prepared using distilled water and
were autoclaved at 121°C for 30 min.
Minimum inhibitory concentration
AgNps antimicrobial activity was evaluated using the mini-
mum inhibitory concentration (MIC) method. The anti-
microbial effectiveness was determined against the final
microorganisms concentration of 106CFU/mL (USP
<51>). The action spectrum makes it possible to ensure
the activity of AgNps stabilized by the different polymers
and of the co-stabilizer pluronic™ F68. The minimum in-
hibitory concentration is expressed as the percentage of
the original AgNps dispersion in the synthesis reaction
medium (a MIC value of 25% indicates a solution contain-
ing 25% of the AgNPs present in the original synthesis dis-
persion). All samples were made in triplicates.
The MIC classic methodology is schematically shown
in Figure 1 [26] and was adapted to 96-well microplates.
300 μL of deionized sterile water were added on the ex-
terior perimeter wells of the microplates to minimize the
evaporation of the culture medium of the test wells du-
ring the incubation.
100 μL of the culture medium were distributed in 12
of the 96 wells, previously sterile, with the exception of
well #1. In the first and second wells of the series,
100 μL of the AgNps dispersion was added. Both wells
were homogenized with the aid of micropipette and
100 μL was transferred from well #2 to well #3. The
transfer was successively repeated until well #11.
10 μL of the inoculum (microorganism tested) in
known concentration, stipulated at 106 CFU/mL, were
added in all wells, with the exception of well #11. The
plate was covered and was incubated at the optimum
growth temperature for the microorganism for 24 h.
Afterwards, the results were studied, inoculating the
content (5 μL) of each well in Petri dishes containing
agar from the specific culture medium tested. The well
with higher dilution was the MIC, in which the absence
of bacterial growth was observed. Wells #11 and #12
were the positivo (Culture medium + inoculum) and
negative controls (Culture medium + antimicrobial), re-
spectively [26].
The same procedure was carried out for the silver ni-
trate for polymers PVA, PVP and pluronic™ F68, indi-
vidually, in order to evaluate if they did not present any
inhibitive effect on the MO.
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